Liste d'obligations internationales ( Toutes )
| Société émettrice | Code ISIN | Devise | Coupon | Montant minimal | Maturité | Prix sur le marché | |
| GlaxoSmithKline Holdings PLC | US377373AJ42 | USD | 2.875% | 2 000 USD | 31/05/2022 | Echue | |
| GlaxoSmithKline Holdings PLC | US377373AG03 | USD | 3% | 2 000 USD | 01/06/2024 | Echue | |
| GlaxoSmithKline Holdings PLC | US377373AH85 | USD | 3.375% | 2 000 USD | 31/05/2029 | 100 | |
| GlaxoSmithKline Holdings PLC | US377373AD71 | USD | 2.85% | 2 000 USD | 07/05/2022 | Echue | |
| GlaxoSmithKline Holdings PLC | XS0294624373 | GBP | 5.25% | 50 000 GBP | 09/04/2042 | 100 | |
| GlaxoSmithKline Holdings PLC | XS2054626358 | EUR | 0.068% | 100 000 EUR | 22/09/2021 | Echue | |
| GlaxoSmithKline Holdings PLC | US377373AL97 | USD | 0.534% | 2 000 USD | 30/09/2023 | Echue | |
| GlaxoSmithKline Holdings PLC | XS2170601848 | GBP | 1.25% | 100 000 GBP | 11/10/2028 | 100 | |
| GlaxoSmithKline Holdings PLC | XS0222383027 | EUR | 4% | 1 000 EUR | 16/06/2025 | Echue | |
| GlaxoSmithKline Holdings PLC | XS0140516864 | GBP | 5.25% | 1 000 GBP | 19/12/2033 | 100 | |
| GlaxoSmithKline Holdings PLC | XS1147605791 | EUR | 1.375% | 02/12/2024 | Echue | ||
| GlaxoSmithKline Holdings PLC | XS1681519184 | EUR | 1% | 12/09/2026 | Echue | ||
| GlaxoSmithKline Holdings PLC | XS1681520356 | EUR | 1.375% | 100 000 EUR | 12/09/2029 | Echue | |
| GlaxoSmithKline Holdings PLC | XS2170609403 | EUR | 0.125% | 100 000 EUR | 12/05/2023 | Echue | |
| GlaxoSmithKline Holdings PLC | XS2054626788 | EUR | 0% | 23/09/2023 | Echue | ||
| GlaxoSmithKline Holdings PLC | XS1822828122 | EUR | 1.25% | 100 000 EUR | 21/05/2026 | Echue | |
| GlaxoSmithKline Holdings PLC | XS1822829799 | EUR | 1.75% | 100 000 EUR | 21/05/2030 | Echue | |
| GlaxoSmithKline Holdings PLC | XS0350820931 | GBP | 6.375% | 50 000 GBP | 08/03/2039 | 104.67 | |
GlaxoSmithKline Capital PLC is a UK-based venture capital firm focused on life sciences investments, primarily supporting early-stage and growth-stage companies developing innovative therapies and technologies within GlaxoSmithKline's strategic areas of interest.
GlaxoSmithKline Capital PLC est une société d'investissement qui gère un portefeuille diversifié d'actifs, principalement axés sur les sciences de la vie et les technologies de la santé, en soutien aux activités de GlaxoSmithKline.
GlaxoSmithKline Capital PLC è una società di investimento del Regno Unito, braccio di investimento di GlaxoSmithKline plc, focalizzata su investimenti in aziende biotecnologiche e farmaceutiche in fase di sviluppo e commercializzazione.